Runner's high — the endocannabinoid hypothesis

TL;DR

• Endorphins are too large to cross the blood-brain barrier.
• Anandamide rises measurably after ≥ 30 min moderate-to-intense endurance.
• Fuss 2015: blocking anandamide abolishes the euphoric feeling.
• Runners with trained ECS report runner's high more strongly and more often.

How can I trigger runner's high?

Study-based threshold: ≥ 30 min at 70-85% HRmax, steady pace, minimal distraction. More frequent in trained athletes (Raichlen 2012). Cannabis or CBD don't replace the physiological adaptation — they modulate the same receptors.

Physiological mechanisms of the endocannabinoid system in sports

As a complex physiological network, the endocannabinoid system (ECS) regulates numerous processes of central importance for athletic recovery and performance. During sustained aerobic exertion, the body releases increased amounts of the endogenous cannabinoid anandamide. This binds to CB1 receptors in the brain as well as to CB2 receptors in the peripheral nervous system and in immune cells. This interaction contributes significantly to pain relief, anti-inflammation, and emotional balance after training. The ECS thus acts as a physiological buffer that protects the body from the stress-related effects of intense physical exertion and restores homeostasis.

In addition, the ECS influences neuronal plasticity and the release of neurotransmitters such as dopamine and serotonin. The activation of cannabinoid receptors during endurance sports modulates synaptic transmission, which explains the typical anxiolytic and mood-enhancing effect of the so-called «runner's high». In the long term, regular endurance training leads to an upregulation of receptor density and a more efficient synthesis of endocannabinoids. Athletes thereby develop a higher sensitivity to these endogenous messengers, causing the phenomenon of exercise-induced euphoria to occur more regularly and intensely in trained individuals.

• Activation of CB1 receptors in the central nervous system for pain modulation.
• Peripheral action via CB2 receptors to reduce inflammatory processes.
• Increase in synaptic plasticity and promotion of neurogenesis in the brain.
• Long-term adaptation of the ECS through regular aerobic endurance training.

Swiss legal situation and road traffic for active sportspeople

For athletes in Switzerland, the legal distinction regarding the consumption of cannabinoids is of great relevance. Hemp products with a total THC content of less than one percent are not considered narcotics under the Swiss Narcotics Act and are legally available. Many athletes use CBD preparations to support recovery. Nevertheless, caution is advised, as even when consuming supposedly THC-free products, small amounts of THC can accumulate in the body. This can lead to legal consequences in road traffic, for example when driving to training, as a strict zero-tolerance policy applies in Switzerland.

The legal limit in road traffic is set at a detection limit of 1.5 micrograms of THC per litre of blood. If this value is exceeded, the person concerned is deemed unfit to drive, which results in the withdrawal of their driving licence and heavy fines. Athletes who use CBD products for recovery should therefore rely exclusively on certified products whose THC content is fully documented. In the case of medically prescribed cannabis, which has been prescribable without an FOPH exceptional permit since August 2022, driving fitness must be assessed on an individual basis to minimize legal risks in everyday life.

• Strict zero-tolerance policy in Swiss road traffic with a limit of 1.5 µg/L of blood.
• The legal threshold for industrial and consumer hemp in Switzerland is below 1 % total THC.
• Medical cannabis has been directly prescribable by Swiss doctors since August 2022.
• Risk of accumulation of trace THC even when using certified CBD products.

Differentiation between exogenous cannabinoids and endogenous runner's high

The assumption that the consumption of exogenous cannabis or CBD can mimic or replace the natural runner's high falls short physiologically. While the body's own anandamide is released in a targeted manner and in fine doses during physical activity, the consumption of exogenous cannabinoids floods the system uncontrollably. This leads to widespread saturation of the receptors, which can disrupt the fine-tuning of the endocannabinoid system. Instead of enhancing athletic performance or well-being, an exogenous excess of THC can impair coordination, prolong reaction times, and unphysiologically increase heart rate.

In addition, a continuous intake of exogenous cannabinoids leads to a downregulation of the body's own receptors. This means that the body reduces the number of CB1 and CB2 receptors to protect itself from overstimulation. As a result, it becomes more difficult for athletes to experience the genuine, exercise-induced runner's high in a natural way. Targeted recovery and physiological adaptation through aerobic training thus remain the only sustainable way to fully exploit the positive experiences of the endocannabinoid system for athletic performance and mental well-being.

• Exogenous cannabinoids flood the system in an untargeted manner and disrupt the body's own delicate regulation.
• Risk of receptor downregulation during chronic exogenous consumption.
• Impairment of coordination, reaction speed, and cardiovascular dynamics by THC.
• The genuine runner's high strictly requires the physical exertion component for anandamide synthesis.

FAQ